Results 171 to 180 of about 2,955,835 (214)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 1995
Stroke is the third leading cause of death in the United States, after coronary heart disease and cancer. There are approximately 500,000 cases of stroke each year; of these, 150,000 are fatal.1 Many survivors are left with mental and physical impairment and require assistance with activities of daily living.
L L, Bronner, D S, Kanter, J E, Manson
openaire +2 more sources
Stroke is the third leading cause of death in the United States, after coronary heart disease and cancer. There are approximately 500,000 cases of stroke each year; of these, 150,000 are fatal.1 Many survivors are left with mental and physical impairment and require assistance with activities of daily living.
L L, Bronner, D S, Kanter, J E, Manson
openaire +2 more sources
Journal of Stroke and Cerebrovascular Diseases, 1991
Aspirin is now standard preventive therapy in patients at risk for stroke, but many questions remain about its efficacy and use. No single trial has clearly demonstrated the efficacy of aspirin for prevention of stroke after transient ischemic attack (TIA). However, almost all studies showed some benefit in the aspirin group.
openaire +2 more sources
Aspirin is now standard preventive therapy in patients at risk for stroke, but many questions remain about its efficacy and use. No single trial has clearly demonstrated the efficacy of aspirin for prevention of stroke after transient ischemic attack (TIA). However, almost all studies showed some benefit in the aspirin group.
openaire +2 more sources
Secondary prevention of stroke
Expert Review of Cardiovascular Therapy, 2009Stroke and transient ischemic attacks result from a range of mechanisms. Secondary prevention includes both conventional approaches to vascular risk-factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy) and more specific interventions, such as carotid endarterectomy or ...
Niall J J, MacDougall +2 more
openaire +2 more sources
Secondary Ischemic Stroke Prevention
Neurotherapeutics, 2023Aaron Bangad +2 more
semanticscholar +1 more source
Extended Risk Factors for Stroke Prevention.
Journal of the National Medical Association, 2019Stroke causes disability and high mortality, while it can be prevented by increasing public awareness of risk factors. The common known risk factors are hypertension, atrial fibrillation, heart failure, smoking, alcohol consumption, low physical activity,
Shuai Zhang, Wei Zhang, Guangqian Zhou
semanticscholar +1 more source
Journal of Cardiovascular Nursing, 2008
Stroke is the most common life-threatening neurological disorder. Based on limited acute therapies, clinicians have opted to focus on preventive strategies to limit its recurrence. Targets for prevention include modifiable risk factors such as hypertension, diabetes mellitus, dyslipidemia, cigarette smoking, obesity, alcohol use, and physical ...
Fred, Rincon, Ralph L, Sacco
openaire +2 more sources
Stroke is the most common life-threatening neurological disorder. Based on limited acute therapies, clinicians have opted to focus on preventive strategies to limit its recurrence. Targets for prevention include modifiable risk factors such as hypertension, diabetes mellitus, dyslipidemia, cigarette smoking, obesity, alcohol use, and physical ...
Fred, Rincon, Ralph L, Sacco
openaire +2 more sources
Thrombosis Research, 2003
According to meta-analyses aspirin provides a relative reduction in the rate of major vascular events of 19% in patients with arterial disease in general, whereas for patients with ischaemic cerebrovascular disease this reduction is only 13%. The discrepancy may well result from pathophysiological differences and not from a play of chance.
J, van Gijn, A, Algra
openaire +2 more sources
According to meta-analyses aspirin provides a relative reduction in the rate of major vascular events of 19% in patients with arterial disease in general, whereas for patients with ischaemic cerebrovascular disease this reduction is only 13%. The discrepancy may well result from pathophysiological differences and not from a play of chance.
J, van Gijn, A, Algra
openaire +2 more sources
Multimodality Stroke Prevention
The Neurologist, 2006Prevention harbors the greatest potential for reducing the societal burden from stroke. As evidence accumulates on the multifactorial pathogenesis of vascular disease and the impact of novel combination therapies targeted at reducing recurrent vascular events, a new paradigm is emerging, which is that of multimodality vascular prevention.
Nerses, Sanossian, Bruce, Ovbiagele
openaire +2 more sources
Current Treatment Options in Neurology, 1999
More than 700,000 strokes occur annually in the United States--one every 40 to 50 seconds. Although stroke is one of the nation's most expensive diseases to treat, costing $41 billion per year, most strokes (perhaps as many as two thirds) are preventable.
, Chaturvedi, , Hickenbottom, , Levine
openaire +2 more sources
More than 700,000 strokes occur annually in the United States--one every 40 to 50 seconds. Although stroke is one of the nation's most expensive diseases to treat, costing $41 billion per year, most strokes (perhaps as many as two thirds) are preventable.
, Chaturvedi, , Hickenbottom, , Levine
openaire +2 more sources
The Lancet Neurology, 2014
Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is often more severe and disabling than the index event. Optimum secondary prevention of recurrent stroke needs rapid diagnosis and treatment and prompt identification of the underlying cardiovascular cause.
openaire +2 more sources
Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is often more severe and disabling than the index event. Optimum secondary prevention of recurrent stroke needs rapid diagnosis and treatment and prompt identification of the underlying cardiovascular cause.
openaire +2 more sources